Calumet Specialty Products Partners (CLMT) Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calumet Specialty Products Partners in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLMT shares.
View CLMT analyst ratings or view top-rated stocks.

4 brokers have issued 1-year price objectives for Calumet Specialty Products Partners' stock. Their CLMT share price forecasts range from $19.50 to $25.00. On average, they anticipate the company's share price to reach $21.88 in the next twelve months. This suggests a possible upside of 37.6% from the stock's current price.
View analysts price targets for CLMT or view top-rated stocks among Wall Street analysts.

Calumet Specialty Products Partners' stock was trading at $16.88 on January 1st, 2023. Since then, CLMT shares have decreased by 5.8% and is now trading at $15.90.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our CLMT earnings forecast.

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) announced its earnings results on Wednesday, March, 15th. The oil and gas company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.17. The oil and gas company had revenue of $999.80 million for the quarter, compared to analyst estimates of $984.85 million. Calumet Specialty Products Partners had a negative net margin of 0.90% and a negative trailing twelve-month return on equity of 14.95%.

18 employees have rated Calumet Specialty Products Partners Chief Executive Officer Tim Go on Glassdoor.com. Tim Go has an approval rating of 42% among the company's employees. This puts Tim Go in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Calumet Specialty Products Partners investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Summit Midstream Partners (SMLP), Viper Energy Partners (VNOM), Washington Prime Group (WPG), Roper Technologies (ROP) and New Residential Investment (NRZ).

Calumet Specialty Products Partners trades on the NASDAQ under the ticker symbol "CLMT."

Calumet Specialty Products Partners' stock is owned by a number of retail and institutional investors. Top institutional investors include Susquehanna International Group LLP (0.00%), FMR LLC (0.77%), Raymond James & Associates (0.37%), Springhouse Capital Management LP (0.18%), LPL Financial LLC (0.18%) and Column Capital Advisors LLC (0.08%). Insiders that own company stock include Daniel J Sajkowski, James S Carter, Louis Todd Borgmann, Ryan Willman, Scott Obermeier and Stephen P Mawer.
View institutional ownership trends.

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLMT stock can currently be purchased for approximately $15.90.

Calumet Specialty Products Partners (NASDAQ:CLMT) has a market capitalization of $1.27 billion and generates $4.69 billion in revenue each year. The oil and gas company earns $-165,100,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.

The company employs 1,530 workers across the globe.

Calumet Specialty Products Partners' mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The official website for the company is www.calumetspecialty.com. The oil and gas company can be reached via phone at (317) 328-5660, via email at investorrelations@clmt.com, or via fax at 317-328-2359.